View in EDS HTML Full Text PDF Full Text

Assessing the post hoc effectiveness of tixagevimab−cilgavimab for prevention of SARS‐CoV‐2 infections in solid organ transplant recipients.

Saved in:
Bibliographic Details
Title: Assessing the post hoc effectiveness of tixagevimab−cilgavimab for prevention of SARS‐CoV‐2 infections in solid organ transplant recipients.
Authors: Jordan, Stanley C.1 (AUTHOR) stan.jordan@cshs.org, Joung, Sandy Y.2 (AUTHOR), Wang, Minhao2 (AUTHOR), Tran, Teresa Anh2 (AUTHOR), Bravo, Michelle2 (AUTHOR), Masoom, Hibah2 (AUTHOR), Chang, Christine2 (AUTHOR), Mendez, Marilyn2 (AUTHOR), Sun, Nancy2 (AUTHOR), Patel, Jignesh2 (AUTHOR), Kittleson, Michelle2 (AUTHOR), Frias, Edwin3 (AUTHOR), Prostko, John C.3 (AUTHOR), Ebinger, Joseph E.2 (AUTHOR), Cheng, Susan2 (AUTHOR) susan.cheng@cshs.org, Sobhani, Kimia4 (AUTHOR)
Source: Transplant Infectious Disease. Feb2024, Vol. 26 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:13982273
DOI:10.1111/tid.14182